Diagnostic and Biotech

North America Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

  • THE3206952
  • 152 Pages
  • February 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The North America human microbiome market is expected to reach US$ 446.39 Mn in 2025 from US$ 113.88 in 2017. The market is estimated to grow with a CAGR of 21.5% from 2018-2025. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome and next-generation sequencing. Whereas, strict government guidelines and lack of knowledge and detailed examination is likely to have a negative impact on the growth of the market in the coming years.

Humans are never alone as they coexist with the diverse microbial species that live within and upon humans. From recent studies it has been very clear that this microbial community is essentially another organ of the body that plays a crucial role in human physiology and disease. Several basic and translational research efforts have been initiated to focus on deciphering mechanisms of microbiome function and how it benefits the human health. Many human medical conditions (like inflammatory bowel diseases and obesity) have been closely associated with or are thought to be influenced by (asthma and diabetes) the composition of the gut microbial community. Many efforts are taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health.

The Human Microbiome Project of the National Institutes of Health in the United States and related international efforts are defining the varieties of a normal microbiome, studying how changes in the microbiota relate to disease. Large governmental research initiatives including the Human Microbiome Project in the U.S. have accelerated research on the human microbiome.

Also, many companies are designing and developing many microbiome therapies. For instance, Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform which is the drug platform for delivering healthy, live, human-derived microbes into a sick patient's intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.

US is anticipated to lead the adoptions of Human microbiome across the North American region through the forecast period. The application of the human microbiome are beneficial for various treatment areas such as cancer, Inflammatory Bowel Disease (IBD), diabetes, autoimmune diseases and more. To be specific with the applications of the human microbiome, it plays important role in the developments in wide range of diseases and disorders which includes cardiovascular disease, cancer, autoimmune, neurological disorders and more. Therefore, various programs are being organized in the country to grow the awareness of probiotics and prebiotics in order to enhance the human microbiome.

For instance, in February 2018, the 3rd Annual North America Microbiome Congress was held in San Diego, by Kisaco Research that focused on 5 microbiome niches such as the gut, lung, oral, skin and vaginal and provided latest insights on microbiome research, clinical trials and collaborative partnerships.

Thus, owing to the above mentioned factors the market for the human microbiome is likely to grow with a significant growth rate in the coming forecast years.

Exhibit: Mexico Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)

NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION

By Product

Probiotics

Foods

Prebiotics

Medical Foods

Diagnostic Device

Drugs

Supplements

NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION

By Disease

Obesity

Diabetes

Autoimmune Disorders

Cancer

Mental Disorders

Others

NORTH AMERICA HUMAN MICROBIOME- MARKET SEGMENTATION

By Application

Therapeutics

Diagnostics

By Country

U.S.

Canada

Mexico

Companies Mentioned

Enterome

MicroBiome Therapeutics, LLC

Rebiotix Inc.

Yakult Honsha Co., Ltd.

Osel Inc.

Vedanta Biosciences, Inc.

Metabiomics Corporate

Synthetic Biologics, Inc.

DuPont

BiomX Ltd.

TABLE OF CONTENTS

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. NORTH AMERICA HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. NORTH AMERICA HUMAN MICROBIOME MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 North America Human Microbiome Market - By Product

3.2.2 North America Human Microbiome Market - By Disease

3.2.3 North America Human Microbiome Market - By Application

3.2.4 North America Human Microbiome Market - By Country

3.3 PEST ANALYSIS

3.3.1 North America - PEST Analysis

PART 4. NORTH AMERICA HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Growing Prevalence of Chronic Diseases

4.1.2 Increasing Research and Development on Human Microbiome-Based Therapies

4.1.3 Rapid adoption of Metagenomics and Next-Generation Sequencing techniques

4.2 KEY MARKET RESTRAINTS

4.2.1 Stringent Regulatory Framework

4.2.2 Lack of Expertise In Human Microbiome

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Developing Fecal Microbiota Transplantation (FMT) Therapies

4.4 FUTURE TRENDS

4.4.1 Growing Human Microbiome Research in Drug Discovery

4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - NORTH AMERICA ANALYSIS

5.1 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS

5.2 MARKET POSITIONING

5.3 PERFORMANCE OF KEY PLAYERS

Enterome

Yakult Honsha Co., Ltd.

5.4 EXPERT OPINIONS

PART 6. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT

6.1 OVERVIEW

6.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

6.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

6.4 FOODS MARKET

6.4.1 Overview

6.4.2 North America Foods Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 MEDICAL FOOD MARKET

6.5.1 Overview

6.5.2 North America Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 PROBIOTICS MARKET

6.6.1 Overview

6.6.2 North America Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 PREBIOTICS MARKET

6.7.1 Overview

6.7.2 North America Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 DRUGS MARKET

6.8.1 Overview

6.8.2 North America Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

6.9 DIAGNOSTIC DEVICES MARKET

6.9.1 Overview

6.9.2 North America Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)

6.10 SUPPLEMENTS MARKET

6.10.1 Overview

6.10.2 North America Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE

7.1 OVERVIEW

7.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)

7.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

7.4 DIABETES MARKET

7.4.1 Overview

7.4.2 North America Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CANCER MARKET

7.5.1 Overview

7.5.2 North America Cancer Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 AUTOIMMUNE DISORDERS MARKET

7.6.1 Overview

7.6.2 North America Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.7 OBESITY MARKET

7.7.1 Overview

7.7.2 North America Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

7.8 MENTAL DISORDERS MARKET

7.8.1 Overview

7.8.2 North America Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.9 OTHERS MARKET

7.9.1 Overview

7.9.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. NORTH AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

8.1 OVERVIEW

8.2 NORTH AMERICA HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)

8.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

8.4 DIAGNOSTICS MARKET

8.4.1 Overview

8.4.2 North America Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 THERAPEUTICS MARKET

8.5.1 Overview

8.5.2 North America Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025

9.1 OVERVIEW

9.2 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

9.4 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

9.5 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

9.6 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

9.7 US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.7.1 US Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.7.2 US Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.7.3 US Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.7.4 US Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8 CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.8.1 Canada Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.8.3 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.8.4 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9 MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.9.1 Mexico Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.9.3 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.9.4 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE

10.1 OVERVIEW

10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

10.3 ORGANIC GROWTH STRATEGIES

10.3.1 Overview

10.3.2 Product Launch & Approvals

10.3.3 Expansion

10.3.4 Patent and license

10.4 INORGANIC GROWTH STRATEGIES

10.4.1 Overview

10.4.2 Acquisitions

10.4.3 Partnerships, Collaborations & Agreements

10.4.4 Joint Ventures

PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES

11.1 ENTEROME

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Product Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 MICROBIOME THERAPEUTICS, LLC

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Information

11.2.4 Product Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 REBIOTIX INC.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Overview

11.3.4 Product Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 YAKULT HONSHA CO., LTD.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Overview

11.4.4 Product Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 OSEL INC.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Product Portfolio

11.5.5 Swot Analysis

11.5.6 Key Developments

11.6 VEDANTA BIOSCIENCES, INC.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Information

11.6.4 Product Portfolio

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 METABIOMICS CORPORATE

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Product Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 SYNTHETIC BIOLOGICS, INC.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Information

11.8.4 Product Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 DUPONT

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Product Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 BIOMX

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Information

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

PART 12. APPENDIX

12.1 ABOUT THE INSIGHT PARTNERS

12.2 GLOSSARY OF TERMS

12.3 METHODOLOGY

12.3.1 Coverage

12.3.2 Secondary Research

12.3.3 Primary Research

LIST OF TABLES

TABLE 1. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 2. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 4. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 5. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 6. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 7. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 8. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 9. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 10. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 11. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 12. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 13. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 14. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 15. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET

TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET

TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET

TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET

TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

FIGURE 1. US HUMAN MICROBIOME MARKET, REVENUE (US$ MN), BY COUNTRIES 2018 & 2025

FIGURE 2. NORTH AMERICA HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017

FIGURE 3. NORTH AMERICA HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017

FIGURE 4. NORTH AMERICA HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017

FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION

FIGURE 6. HUMAN MICROBIOME SEGMENTATION, BY REGION

FIGURE 7. NORTH AMERICA PEST ANALYSIS

FIGURE 8. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 9. NORTH AMERICA HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 10. NORTH AMERICA HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

FIGURE 11. NORTH AMERICA FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 12. NORTH AMERICA MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. NORTH AMERICA PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. NORTH AMERICA PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. NORTH AMERICA DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 16. NORTH AMERICA DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. NORTH AMERICA SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 18. NORTH AMERICA HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)

FIGURE 19. NORTH AMERICA DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. NORTH AMERICA CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. NORTH AMERICA AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 22. NORTH AMERICA OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 23. NORTH AMERICA MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 25. NORTH AMERICA HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 26. NORTH AMERICA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. NORTH AMERICA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 28. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)

FIGURE 29. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 30. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 31. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 32. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 33. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 34. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 35. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 36. INORGANIC GROWTH STRATEGIES IN THE ENDOSCOPY DEVICE MARKET, 2015-2018

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370